CYP 2.33% 21.0¢ cynata therapeutics limited

Phase 1 interim results imminent, page-90

  1. 1,848 Posts.
    lightbulb Created with Sketch. 218
    Couldn't patients with GvHD anywhere in the UK though get transfers for treatments at those hospitals?

    The condition is generally fatal so why wouldn't patients be trying hard to get into the trial irrespective of the number of hospitals?

    Would anyone with refractory GvHD NOT have their doctors looking for such trials?
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.